RARα1 inhibitors are a class of chemical compounds that specifically target and inhibit the function of the retinoic acid receptor alpha isoform 1 (RARα1), a nuclear receptor involved in regulating gene expression in response to retinoic acid, a metabolite of vitamin A. RARα1, as part of the RARα family, plays a pivotal role in mediating the effects of retinoic acid by binding to specific DNA sequences known as retinoic acid response elements (RAREs) in the promoter regions of target genes. When RARα1 binds to retinoic acid, it forms heterodimers with retinoid X receptors (RXRs), which then regulate the transcription of genes involved in various biological processes such as cellular differentiation, proliferation, and homeostasis. RARα1 is distinct from other RAR isoforms due to its tissue-specific expression and regulatory roles in certain physiological functions. Inhibitors of RARα1 typically act by binding to its ligand-binding domain or interfering with its DNA-binding activity, thereby blocking the receptor's ability to modulate gene transcription in response to retinoic acid.
The inhibition of RARα1 disrupts retinoic acid signaling pathways, leading to altered gene expression patterns and affecting processes such as cell differentiation and growth. By preventing RARα1 from functioning correctly, these inhibitors can interfere with the transcriptional regulation of genes that are critical for maintaining normal cellular function and developmental processes. Researchers use RARα1 inhibitors to investigate the specific roles of this isoform in gene regulation and to differentiate the functions of RARα1 from other RAR isoforms, such as RARα2. These inhibitors provide valuable insights into how RARα1 contributes to retinoic acid-mediated signaling and how its unique regulatory mechanisms influence cellular behavior. Additionally, RARα1 inhibitors help researchers understand the broader regulatory networks that control nuclear receptor activity and how these receptors coordinate complex physiological responses to external stimuli like retinoic acid. Through the study of RARα1 inhibitors, scientists can gain a more detailed understanding of the molecular mechanisms underlying nuclear receptor function and gene regulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid may act as an agonist to RARα1, potentially leading to downregulation of its expression through negative feedback mechanisms. | ||||||
Bexarotene | 153559-49-0 | sc-217753 sc-217753A | 10 mg 100 mg | $55.00 $250.00 | 6 | |
Bexarotene, by activating RXR, may lead to a competitive inhibition of RARα1, resulting in decreased expression due to altered heterodimerization. | ||||||
13-cis-Retinoic acid | 4759-48-2 | sc-205568 sc-205568A | 100 mg 250 mg | $75.00 $120.00 | 8 | |
13-cis-Retinoic acid's action as an agonist might trigger a decrease in RARα1 expression due to a homeostatic response to sustained receptor activation. | ||||||
Acitretin | 55079-83-9 | sc-210754 | 25 mg | $151.00 | 1 | |
Acitretin may bind directly to RARα1, causing a transcriptional repression of its target genes, which could include RARα1 itself. | ||||||
AM 580 | 102121-60-8 | sc-203505 sc-203505A | 5 mg 25 mg | $99.00 $390.00 | 2 | |
AM 580, a potent RARα agonist, may exert a negative feedback control, leading to the downregulation of RARα1 gene expression. | ||||||
AM 80 | 94497-51-5 | sc-203816 sc-203816A | 10 mg 50 mg | $155.00 $620.00 | 1 | |
AM 80 might cause transcriptional repression of its own receptor, RARα1, as a homeostatic response to activation. | ||||||
Vitamin A | 68-26-8 | sc-280187 sc-280187A | 1 g 10 g | $385.00 $2654.00 | ||
Vitamin A's metabolites could act as endogenous ligands for RARα1, initiating a decrease in expression through feedback inhibition. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $63.00 $265.00 | 21 | |
Ketoconazole inhibits cytochrome P450 enzymes, which could lead to altered retinoid metabolism and subsequent downregulation of RARα1 expression. | ||||||
Chrysin | 480-40-0 | sc-204686 | 1 g | $38.00 | 13 | |
By inhibiting aromatase, Chrysin could potentially reduce estrogen levels, thereby indirectly causing a decrease in RARα1 expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid, through histone acetylation, may cause chromatin remodeling that leads to decreased transcription of the RARα1 gene. | ||||||